Human Chorionic Gonadotropin (HCG) Research Overview

Simplified Summary

Human chorionic gonadotropin is a dimeric glycoprotein produced by the syncytiotrophoblast during pregnancy and used as a research tool due to its high affinity for the luteinising hormone receptor (LHR). In male reproductive biology research, hCG has been studied for its ability to stimulate Leydig cell testosterone production through LHR-mediated cAMP signalling. In female reproductive research, hCG serves as an LH-surge surrogate in ovarian stimulation model systems. Preclinical research has used hCG to characterise LHR pharmacology, gonadal steroidogenesis pathways, and reproductive axis biology in laboratory settings.

Key Findings Reported in Preclinical Models

• LH receptor binding and cAMP signalling pathway activation characterised in Leydig cell and granulosa cell culture systems.
• Testosterone production stimulation in preclinical Leydig cell research models.
• Ovarian follicle maturation and luteinisation effects characterised in preclinical reproductive biology model systems.
• HPG axis modulation in animal models examining how LHR activation influences hypothalamic-pituitary-gonadal feedback.

Introduction

hCG has a longer plasma half-life than LH due to its high degree of glycosylation, making it a convenient pharmacological surrogate for LH in research settings requiring sustained LHR stimulation. Its use as a research tool spans reproductive endocrinology, steroidogenesis biology, and HPG axis research across cell culture and animal model systems.

Research Applications

• Leydig cell biology research examining steroidogenesis pathways and testosterone biosynthesis under LHR stimulation.
• Ovarian biology research studying follicle maturation, luteinisation, and progesterone production in relevant preclinical model systems.
• HPG axis research examining LHR agonist effects on gonadal and hypothalamic-pituitary feedback in animal models.